Current Opinion in Pharmacology

Papers
(The TQCC of Current Opinion in Pharmacology is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Editorial Board147
Lipid raft disruption as an opportunity for peripheral analgesia73
Corrigendum to “From “contraindicated” to “first line” – Current mechanistic insights beyond canonical β-receptor signaling” [COPHAR 76 (2024) 102458]68
Advances in pain therapeutics: Targets, mechanisms, and translational frontiers61
Native botulinum toxin type A vs. redesigned botulinum toxins in pain: What did we learn so far?48
Targeting strategies and immune regulatory mechanisms of CAR-macrophages in the treatment of osteosarcoma48
From “contraindicated” to “first line” – Current mechanistic insights beyond canonical β-receptor signaling42
The P2X7 purinoceptor in pathogenesis and treatment of dystrophino- and sarcoglycanopathies36
The role of extracellular ATP in homeostatic immune cell migration35
Recent advances in emerging PCOS therapies34
The neuro-metabolic epidemic and the CB1R paradox34
Therapeutic hurdles in acute myeloid leukemia: Leukemic stem cells, inflammation and immune dysfunction33
Lipidomics-driven insights into acupuncture mechanisms: From dynamic signaling networks to multi-dimensional regulations28
Editorial Board28
Gastrointestinal issue: Advances in gastrointestinal oncology27
CRISPR-Cas9 in acute myeloid leukaemia: Current state-of-art and future perspectives26
Auricular stimulation therapy: An evidence-based practice strategy for depression25
Optic nerve regeneration: Potential treatment approaches25
Considerations for individualized first-line systemic treatment in advanced hepatocellular carcinoma25
Editorial Board24
Editorial overview: Special issue on “Rheumatology: Therapeutic advances for autoimmune and musculoskeletal diseases”24
Advanced microneedle arrays for transdermal antibiotic delivery24
Editorial Board22
Pharmaceutical therapies targeting autophagy for the treatment of age-related macular degeneration22
Innovative pipeline therapeutics in inflammatory bowel disease: Anti-tumor necrosis factor-like ligand 1A and bispecific antibodies21
Editorial Board21
Pharmacological targeting of neuroimmune-synaptic interactions in Alzheimer's disease: integrating NETosis, microglia, and synaptic vulnerability21
Therapeutic approaches in different congenital myopathies20
Current state of CFTR modulators for treatment of Cystic Fibrosis20
Allogeneic double-negative T-cell therapy for acute myeloid leukemia20
Gene therapies for RyR1-related myopathies19
Methotrexate: Integrating molecular pharmacology, systems toxicology, and precision rescue strategies19
Targeting TRP channels for pain relief: A review of current evidence from bench to bedside19
Targeting the ischemic cascade: Review on approved and investigational stroke therapies19
Valproic acid: Mechanistic insights into neuronal actions, epigenetic modulation, and clinical risk19
Transcutaneous electrical nerve stimulation and opioid analgesia: Exploring a potential synergistic relationship19
Acupuncture and non-invasive neuromodulation–induced neuro-endocrine-immune changes associated with the amelioration of depression-like behaviors: A systematic review of animal studies19
Oligonucleotide-based therapies for cystic fibrosis17
Strategies to enhance anti-leukaemia immunotherapy17
Oncohistone-sculpted epigenetic mechanisms in pediatric brain cancer17
Riluzole in neuroinflammation and neurodegeneration: Mechanistic insights and experimental validation17
Lipids and lipid regulators in intraocular pressure homeostasis17
Drug development for the treatment of RyR1-related skeletal muscle diseases16
Chrono-immunotherapy in precision oncology: Circadian control of the tumor microenvironment and time-of-day optimization of immune checkpoint blockade15
Smart solutions for tough infections: The rise of next-gen transdermal drug delivery15
The role of plant-derived compounds in anti-obesity drug discovery: A molecular perspective15
Estrogen related receptor alpha: Potential modulator of age-related macular degeneration15
Editorial overview: “Purinergic immune cell regulation reveals novel pharmacological targets”14
NanoPhyto formulations: A promising approach for targeted therapy of gastrointestinal infections, clinical advancements, and future perspectives14
Purinergic signalling in graft-versus-host disease14
Shaping DNA damage responses: Therapeutic potential of targeting telomeric proteins and DNA repair factors in cancer14
Acupuncture for depression: Decoding neuroimmune crosstalk and targeting anti-inflammatory mechanisms14
TMEM16A regulates MUC5AC production in airway diseases: A comprehensive review13
Functional role of the ER stress transducer IRE1α in CF airway epithelial inflammation13
Targeting the NRF2 pathway: A promising approach for corneal endothelial dysfunction13
Advancements in targeted therapies for acute myeloid leukemia13
Personalizing nutrition therapy in inflammatory bowel disease: Practical applications and review of the latest studies13
Highlighting vulnerabilities in the alternative lengthening of telomeres pathway13
Editorial overview: COVID-19 therapy: From lung disease to systemic disorder13
Challenges in formulating transdermal systems for treating chronic skin infections13
Antibiotics, the microbiome and gastrointestinal cancers: A causal interference?12
State-dependent neurotensin modulation in the brain: From network dynamics to pharmacological opportunity12
Editorial overview: Introduction to the musculoskeletal section of current opinion in pharmacology12
Targeting fibroblast-like synoviocytes in rheumatoid arthritis12
1.4891610145569